Hikma Pharmaceutical | HIK - Equity Capital And Reserves

Stock Price
1,552.00
Daily Change
-80.00 -4.90%
Monthly
-2.08%
Yearly
-32.35%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $2.55B in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Almirall EUR 1.46B 25.28M Jun/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Autolus Therapeutics Ltd USD 265.45M 81.01M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Fresenius EUR 18.62B 320M Sep/2025
Galapagos EUR 2.45B 196.86M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.94B 677M Sep/2025
Orion EUR 1.02B 99.5M Sep/2025
Recordati EUR 1.93B 57.32M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024